Anavex Life Sciences Corp. SEC filings AVXL
Anavex Life Sciences Corp. has 634 filings in SEC EDGAR's recent list, going back to Jan 13, 2005. Its latest annual report, Form 10-K, was filed on Nov 25, 2025 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 28, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (officer or director change). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K/A | Amended annual report | Aug 28, 2026 | Sep 30, 2025 |
| 10-K | Annual report | Nov 25, 2025 | Sep 30, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Sep 30, 2024 |
| 10-K | Annual report | Dec 23, 2024 | Sep 30, 2024 |
| 10-K | Annual report | Nov 27, 2023 | Sep 30, 2023 |
| 10-K/A | Amended annual report | Jan 27, 2023 | Sep 30, 2022 |
| 10-K | Annual report | Nov 28, 2022 | Sep 30, 2022 |
| 10-K | Annual report | Nov 24, 2021 | Sep 30, 2021 |
| 10-K | Annual report | Dec 28, 2020 | Sep 30, 2020 |
| 10-K | Annual report | Dec 16, 2019 | Sep 30, 2019 |
| 10-K/A | Amended annual report | Jan 25, 2019 | Sep 30, 2018 |
| 10-K | Annual report | Dec 12, 2018 | Sep 30, 2018 |
| 10-K | Annual report | Dec 11, 2017 | Sep 30, 2017 |
| 10-K | Annual report | Dec 14, 2016 | Sep 30, 2016 |
| 10-K | Annual report | Dec 29, 2015 | Sep 30, 2015 |
| 10-K | Annual report | Dec 29, 2014 | Sep 30, 2014 |
| 10-K | Annual report | Dec 30, 2013 | Sep 30, 2013 |
| 10-K | Annual report | Dec 31, 2012 | Sep 30, 2012 |
| 10-K | Annual report | Dec 22, 2011 | Sep 30, 2011 |
| 10-K/A | Amended annual report | Mar 17, 2011 | Sep 30, 2010 |
| ARS | Annual report to shareholders | Mar 7, 2011 | Sep 30, 2010 |
| 10-K | Annual report | Dec 27, 2010 | Sep 30, 2010 |
| ARS | Annual report to shareholders | Apr 2, 2010 | Sep 30, 2009 |
| 10-K | Annual report | Dec 24, 2009 | Sep 30, 2009 |
| ARS | Annual report to shareholders | Mar 2, 2009 | Sep 30, 2008 |
| 10-K | Annual report | Jan 13, 2009 | Sep 30, 2008 |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- AVXL (Nasdaq)
- Fiscal year ends
- September 30
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer, Smaller reporting company
- SEC CIK
- 1314052
- Former names
- Thrifty Printing Inc. (until Jan 25, 2007)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.